🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07561619
Starting soon Phase 2/3

Yeast Protein for Muscle Mass

NCT07561619 · tracked via the Priya Life Science Canada tracker
Phase
Phase 2/3
Started
2026-09
Last updated
2026-09-09

Condition(s) studied

Healthy Adult Participants

Investigational drug(s) / intervention(s)

Yeast ProteinResistance Training ExercisesWhey Protein

Yeast Protein: 60g of protein supplement (40g of protein). Oral administration, 30g during exercise and anytime after exercise, or 30g in the morning and evening if no exercise is performed for a period of 16 weeks.

Resistance Training Exercises: Lower and upper body resistance training exercises 3 times a week for 16 weeks

Whey Protein: 60g of protein supplement (40g of protein). Oral administration, 30g during exercise and anytime after exercise, or 30g in the morning and evening if no exercise is performed for a period of 16 weeks.

Study summary

Protein supplementation is said to be one of the cost-efficient and practical strategies to meet protein needs for growth and exercise, and can help maximize muscle gain from resistance exercise. It facilitates faster recovery from stress-induced tissue damage and enhances performance output. Protein sources derived from animal products are generally recognized as the highest quality protein. However, altering the protein composition of a protein source can improve the protein quality. The yeast protein supplement the investigators will use in this study has a similar amino acid composition to whey protein, which is derived from an animal product, but it is produced more sustainably. The study aims to compare the effects of yeast and whey protein on muscle mass over 16 weeks.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up. * Prior resistance training experience (defined as performing resistance exercises \>1/week for the past 3 months or longer) to enable them to reach a large training stimulus relatively quickly and to avoid the longer phase of neuromuscular adaptations * ≥18 years and \<35 years of age Exclusion Criteria: * Diabetes, musculoskeletal disease, cancer, Crohn's disease, or any other acute or chronic condition that interferes (or the medication prescribed for those conditions) with muscle anabolism. * Diagnosed with or being treated for heart disease, stroke, high blood pressure 130/80 mmHg or higher * Pain/discomfort/pressure in the chest during activities of daily living or physical activity * Pregnant or not on adequate contraception. * A known hypersensitivity/allergy to ingredients in the supplements. * Inflammatory bowel diseases * Enrolment in any other clinical protocol or investigational study that may interfere with study procedures * Taking antibiotics

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The University of Alberta North Campus Edmonton Alberta

More University of Alberta trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07561619 on ClinicalTrials.gov ↗ ← All trials in Canada